Summit Therapeutics
SMMT
#2244
Rank
HK$62.37 B
Marketcap
HK$77.99
Share price
-5.87%
Change (1 day)
-38.10%
Change (1 year)

Earnings for Summit Therapeutics (SMMT)

Earnings in 2026 (TTM): -HK$6.52 Billion

According to Summit Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -HK$8.47 Billion a decrease over its 2024 earnings that were of -HK$1.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Summit Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$6.52 Billion-22.99%
2025 -HK$8.47 Billion387.84%
2024 -HK$1.74 Billion-64.01%
2023 -HK$4.83 Billion680.54%
2022 -HK$0.62 Billion-11.08%
2021 -HK$0.7 Billion67.46%
2020 -HK$0.42 Billion29.71%
2019 -HK$0.32 Billion
2014 -HK$0.26 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-HK$1.03 Billion-84.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-HK$17.71 Million-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
-HK$1.2 Billion-81.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-HK$4.92 Billion-24.71%๐Ÿ‡บ๐Ÿ‡ธ USA